Quattrone, Diego
 Distribuzione geografica
Continente #
NA - Nord America 2.538
EU - Europa 911
AS - Asia 227
AF - Africa 15
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
SA - Sud America 2
Totale 3.699
Nazione #
US - Stati Uniti d'America 2.527
IT - Italia 511
GB - Regno Unito 87
SG - Singapore 81
CN - Cina 73
DE - Germania 67
FR - Francia 36
FI - Finlandia 35
IE - Irlanda 31
SE - Svezia 24
RU - Federazione Russa 21
RO - Romania 20
ES - Italia 18
KR - Corea 15
NL - Olanda 15
HK - Hong Kong 11
IN - India 11
CI - Costa d'Avorio 10
TW - Taiwan 10
CA - Canada 9
UA - Ucraina 9
GR - Grecia 8
TR - Turchia 7
CH - Svizzera 6
AT - Austria 5
BE - Belgio 5
IR - Iran 5
PK - Pakistan 5
EG - Egitto 4
EU - Europa 3
PL - Polonia 3
AU - Australia 2
BG - Bulgaria 2
CZ - Repubblica Ceca 2
JP - Giappone 2
MX - Messico 2
PH - Filippine 2
AL - Albania 1
AR - Argentina 1
BD - Bangladesh 1
BR - Brasile 1
DK - Danimarca 1
HR - Croazia 1
IL - Israele 1
KH - Cambogia 1
LV - Lettonia 1
MO - Macao, regione amministrativa speciale della Cina 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 3.699
Città #
Fairfield 431
Ashburn 321
Chandler 218
Woodbridge 178
Houston 168
Wilmington 153
Seattle 146
Palermo 131
Ann Arbor 124
Cambridge 119
Medford 70
Singapore 53
Boardman 51
Altamura 42
Des Moines 40
Princeton 40
Lawrence 37
San Diego 34
Dublin 31
Lappeenranta 28
Ludwigshafen am Rhein 24
Rome 23
London 18
Beijing 17
Redwood City 15
Alimena 14
Seoul 14
Dearborn 13
Falls Church 13
New York 13
Nanjing 12
San Paolo di Civitate 11
Tower Hamlets 11
Abidjan 10
Central 10
Milan 10
Washington 10
Florence 9
Kumar 8
Phoenix 8
Alcalá de Henares 7
Saint Petersburg 7
Tainan City 7
Amsterdam 6
Bologna 6
Helsinki 6
Los Angeles 6
Pescara 6
Wandsworth 6
Bergamo 5
Catania 5
Padova 5
Paris 5
Shenyang 5
Agrigento 4
Brussels 4
Girona 4
Groningen 4
Hangzhou 4
Karachi 4
Lakewood 4
Munich 4
Nanchang 4
Santa Clara 4
Taizhou 4
Tulsa 4
Turin 4
Vienna 4
Brooklyn 3
Capaci 3
Changsha 3
Esslingen am Neckar 3
Fremont 3
Guangzhou 3
Jiaxing 3
Jinan 3
Latina 3
Messina 3
Nuremberg 3
Rovigo 3
Taipei 3
Tehran 3
Tianjin 3
Volturara Irpina 3
Aragona 2
Athens 2
Bari 2
Berlin 2
Bilbao 2
Boise 2
Cairo 2
Calci 2
Cardiff 2
Caserta 2
Cuauhtémoc 2
Exeter 2
Gunten 2
Hanover 2
Hebei 2
Hounslow 2
Totale 2.896
Nome #
Treated incidence of psychotic disorders in the multinational EU-GEI study 222
Transdiagnostic dimensions of psychopathology at first episode psychosis: findings from the multinational EU GEI study 196
The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study 165
Jumping to conclusions, general intelligence, and psychosis liability: findings from the multi-centre EU-GEI case-control study 162
Premorbid Adjustment and IQ in Patients With First-Episode Psychosis: A Multisite Case-Control Study of Their Relationship With Cannabis Use 146
The Relationship Between Polygenic Risk Scores and Cognition in Schizophrenia 136
Risk factors for internet gaming disorder in a sample of 5,979 italian online gamers. 135
Daily use of high-potency cannabis is associated with more positive symptoms in first-episode psychosis patients: The EU-GEI case-control study 134
DOES POLYGENIC RISK SCORE FOR SCHIZOPHRENIA IMPACT ON JUMPING TO CONCLUSIONS? PRELIMINARY FINDINGS FROM THE EU-GEI CASE-CONTROL STUDY 131
IQ differences between patients with first episode psychosis in London and Palermo reflect differences in patterns of cannabis use. 128
Prevalence and Risk Factors for Internet Gaming Disorder (IGD) in a sample of 5,979 Italian Online Gamers 126
BIOLOGICAL AND EPIDEMIOLOGICAL EXAMINATION OF TRANSDIAGNOSTIC AND SPECIFIC SYMPTOM DIMENSIONS AT PSYCHOSIS ONSET: FINDINGS FROM THE EUGEI STUDY 123
The influence of risk factors on the onset and outcome of psychosis: What we learned from the GAP study 118
The EUropean Network of National Schizophrenia Networks Studying Gene–Environment Interactions (EU-GEI): Incidence and First-Episode Case–Control Programme 116
F115POLYGENIC RISK SCORES FOR SCHIZOPHRENIA, BIPOLAR, AND MAJOR DEPRESSIVE DISORDERS PREDICT TRANSDIAGNOSTIC SYMPTOM DIMENSIONS AT FIRST EPISODE PSYCHOSIS 113
Are Polygenic Risk Scores for Major Mental Disorders Associated with General or Specific Psychosis Symptom dimensions? 112
FIRST EPISODE PSYCHOTIC PATIENTS WITH A HISTORY OF FREQUENT CANNABIS USE EXPRESS MORE POSITIVE SYMPTOMS AT ILLNESS ONSET THAN THOSE WHO NEVER USED CANNABIS 111
The Relationship Between Dissociative Experiences and Cannabis Use: a Systematic Review 110
Association of extent of cannabis use and psychotic like intoxication experiences in a multi-national sample of first episode psychosis patients and controls 106
DOES CANNABIS USE WORSEN PSYCHOTIC SYMPTOM PRESENTATION? 100
O4.8. CAN YOU SPOT EMOTIONS? FACIAL EMOTION RECOGNITION AND GENETIC RISK FOR PSYCHOSIS 91
FIRST EPISODE PSYCHOSIS PATIENTS WHO USED CANNABIS DEVELOP THEIR ILLNESS AT A SIGNIFICANTLY YOUNGER AGE THAN THOSE WHO NEVER USED CONSISTENTLY ACROSS EUROPE AND BRAZIL 83
What does augment the risk to use cannabis on an everyday-basis in psychotic patients? 81
O3.1. ASSOCIATION OF EXTENT OF CANNABIS USE AND ACUTE INTOXICATION EXPERIENCES IN A MULTI-NATIONAL SAMPLE OF FIRST EPISODE PSYCHOSIS PATIENTS AND CONTROLS 76
JUMPING TO CONCLUSIONS AND FACIAL EMOTION RECOGNITION IMPAIRMENT IN FIRST EPISODE PSYCHOSIS ACROSS EUROPE 73
T42. JUMPING TO CONCLUSIONS IS ASSOCIATED WITH THE POLYGENIC RISK SCORE FOR INTELLIGENCE BUT NOT FOR SCHIZOPHRENIA. PRELIMINARY FINDINGS FROM THE EU-GEI STUDY 69
IS THE ERA OF CANDIDATE GENES X CANNABIS USE REALLY DEAD? 68
Differences between female and male gamers and gender-specific risk-factors for internet gaming disorder (IGD) 66
Facial Emotion Recognition in Psychosis and Associations With Polygenic Risk for Schizophrenia: Findings From the Multi-Center EU-GEI Case-Control Study 62
SOME OF THE INDIVIDUAL DIFFERENCES IN RISK TO DEVELOP PSYCHOSIS AMONG CANNABIS USERS CAN BE EXPLAINED BY WHERE THEY LIVE AND BY THEIR AGE AT FIRST USE 58
FIRST EPISODE PSYCHOSIS PATIENTS ACROSS EUROPE DIFFER IN INTELLECTUAL QUOTIENT (IQ) AND EXPOSURE TO ENVIRONMENTAL HAZARDS 54
Migration history and risk of psychosis: Results from the multinational EU-GEI study 53
COGNITION, METACOGNITION AND SOCIAL COGNITION AFTER A FIRST EPISODE PSYCHOSIS. PRELIMINARY RESULTS FROM A 5-YEAR-FOLLOW-UP STUDY 51
Pre-training inter-rater reliability of clinical instruments in an international psychosis research project 48
P.0170 Distinct polygenic risk scores in clusters of psychotic subjects with different premorbid trajectories and current IQ 46
ENVIRONMENTAL RISK FACTORS DIFFERENCES AMONG DIAGNOSTIC CATEGORIES IN EU-GEI STUDY 46
EXPLORING SPECIFIC EFFECTS OF TYPE AND TIMING OF EXPOSURE TO CHILDHOOD ADVERSITY AND SYMPTOM DOMAINS IN FIRST EPISODE OF PSYCHOSIS: PRELIMINARY RESULTS FROM THE EUGEI PROJECT 44
Perceived major experiences of discrimination, ethnic group, and risk of psychosis in a six-country case-control study 43
P.0171 The independent and joint effect of the endocannabinoid system and daily cannabis use on the risk of psychosis 32
Childhood Maltreatment, Educational Attainment, and IQ: Findings From a Multicentric Case-control Study of First-episode Psychosis (EU-GEI) 31
The relationship between genetic liability, childhood maltreatment, and IQ: findings from the EU-GEI multicentric case-control study 31
Use of multiple polygenic risk scores for distinguishing schizophrenia-spectrum disorder and affective psychosis categories in a first-episode sample; the EU-GEI study 30
First-Episode Psychosis Patients Who Deteriorated in the Premorbid Period Do Not Have Higher Polygenic Risk Scores Than Others: A Cluster Analysis of EU-GEI Data 24
Mapping genomic loci implicates genes and synaptic biology in schizophrenia 24
The Kraepelian concept of schizophrenia: Dying but not yet dead 19
Tobacco use in first-episode psychosis, a multinational EU-GEI study 15
Transdiagnostic dimensions of symptoms and experiences associated with immune proteins in the continuity of psychosis 15
Duration of untreated disorder and cannabis use: An observational study on a cohort of young italian patients experiencing psychotic experiences and dissociative symptoms 15
Genetics for mental health clinicians: a call for a globally accessible and equitable psychiatric genetics education 14
The increased incidence of psychosis during the COVID-19 pandemic in South London: The role of heavy cannabis use 13
Differences in Patterns of Stimulant Use and Their Impact on First-Episode Psychosis Incidence: An Analysis of the EUGEI Study 12
The Role of Social Deprivation and Cannabis Use in Explaining Variation in the Incidence of Psychotic Disorders: Findings From the EU-GEI Study 12
Cannabis use as a potential mediator between childhood adversity and first-episode psychosis: results from the EU-GEI case-control study 12
Differential gene expression analysis in blood of first episode psychosis patients 12
Do Idiopathic Parkinson's Disease and Schizophrenia Lie on the Same Genetic Spectrum? 12
Child maltreatment, migration and risk of first-episode psychosis: results from the multinational EU-GEI study 11
Antipsychotic dose mediates the association between polypharmacy and corrected QT interval 11
The effect of the COVID-19 pandemic on the treated incidence of psychotic disorders in South London 11
Traditional marijuana, high-potency cannabis and synthetic cannabinoids: increasing risk for psychosis 10
35.4 A PUBLIC HEALTH APPROACH TO THE PREVENTION OF PSYCHOSIS 10
Novel psychoactive substances in young adults with and without psychiatric comorbidities 10
First-generation antipsychotics and QTc: any role for mediating variables? 10
Prevalence and correlates of QTc prolongation in Italian psychiatric care: Cross-sectional multicentre study 10
Abnormal illness behavior and Internet addiction severity: The role of disease conviction, irritability, and alexithymia 9
Does personality matter? Temperament and character dimensions in panic subtypes 9
The RS685012 Polymorphism of ACCN2, the Human Ortholog of Murine Acid-Sensing Ion Channel (ASIC1) Gene, is Highly Represented in Patients with Panic Disorder 9
Novel psychoactive substances and induced phenomena in psychopathology: The lysergic psychoma 9
Letter to the editor: Is polygenic risk for Parkinson's disease associated with less risk of first episode psychosis? 9
Effects of continuation, frequency, and type of cannabis use on relapse in the first 2 years after onset of psychosis: an observational study 9
Unraveling Exercise Addiction: The Role of Narcissism and Self-Esteem 9
58.1 Cannabis use Across Europe: A Ticket to Psychosis? 9
F68. PREMORBID IQ, EDUCATIONAL LEVEL AND JUMPING TO CONCLUSIONS AS PREDICTORS OF CLINICAL OUTCOME AT FIRST ONSET OF PSYCHOSIS OVER THE NEXT 4 YEARS: THE GAP STUDY 8
A prediction modelling and pattern detection approach for the first-episode psychosis associated to cannabis use 8
Jumping to conclusions at first onset of psychosis predicts longer admissions, more compulsory admissions and police involvement over the next 4 years: the GAP study 8
Novel psychoactive substance consumption is more represented in bipolar disorder than in psychotic disorders: A multicenter-observational study 8
Should psychiatrists be more cautious about the long-term prophylactic use of antipsychotics? 7
The contribution of cannabis use to the increased psychosis risk among minority ethnic groups in Europe 7
Variation of subclinical psychosis across 16 sites in Europe and Brazil: findings from the multi-national EU-GEI study 7
Substance-induced psychosis and schizophrenia: the interaction point 6
The association between reasons for first using cannabis, later pattern of use, and risk of first-episode psychosis: the EU-GEI case-control study 6
Totale 4.345
Categoria #
all - tutte 18.731
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.731


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020822 0 18 17 61 61 72 73 74 181 72 106 87
2020/2021856 51 70 66 47 38 37 150 97 80 91 63 66
2021/2022669 44 86 19 33 32 67 27 98 52 58 57 96
2022/2023781 73 138 30 57 79 141 39 49 88 14 58 15
2023/2024742 14 46 17 79 45 54 83 31 1 42 37 293
2024/2025199 161 38 0 0 0 0 0 0 0 0 0 0
Totale 4.345